Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison
    Ian Alberts
    George Prenosil
    Christos Sachpekidis
    Thilo Weitzel
    Kuangyu Shi
    Axel Rominger
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 614 - 623
  • [42] Total-body [68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer
    Wang, Yining
    Chen, Zijun
    Zhu, Yinjie
    Zhao, Haitao
    Li, Lianghua
    Huang, Gang
    Xue, Wei
    Chen, Ruohua
    Liu, Jianjun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (13) : 4096 - 4106
  • [43] Total-body [68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer
    Yining Wang
    Zijun Chen
    Yinjie Zhu
    Haitao Zhao
    Lianghua Li
    Gang Huang
    Wei Xue
    Ruohua Chen
    Jianjun Liu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 4096 - 4106
  • [44] Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer
    Sander Jentjens
    Cindy Mai
    Niloefar Ahmadi Bidakhvidi
    Liesbeth De Coster
    Nathalie Mertens
    Michel Koole
    Wouter Everaerts
    Steven Joniau
    Raymond Oyen
    Koen Van Laere
    Karolien Goffin
    European Radiology, 2022, 32 : 901 - 911
  • [45] Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer
    Ghezzo, Samuele
    Mapelli, Paola
    Bezzi, Carolina
    Samanes Gajate, Ana Maria
    Brembilla, Giorgio
    Gotuzzo, Irene
    Russo, Tommaso
    Preza, Erik
    Cucchiara, Vito
    Ahmed, Naghia
    Neri, Ilaria
    Mongardi, Sofia
    Freschi, Massimo
    Briganti, Alberto
    De Cobelli, Francesco
    Gianolli, Luigi
    Scifo, Paola
    Picchio, Maria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2548 - 2560
  • [46] AUTOMATED ASSESSMENT OF LESION HETEROGENEITY FOR METASTATIC PROSTATE CANCER PATIENTS USING (68Ga) Ga-PSMA-11 PET/CT IMAGES
    Dell'Oro, Mikaela
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 40 - 41
  • [47] Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
    Fassbender, Thomas Franz
    Schiller, Florian
    Zamboglou, Constantinos
    Drendel, Vanessa
    Kiefer, Selina
    Jilg, Cordula A.
    Grosu, Anca-Ligia
    Mix, Michael
    EJNMMI RESEARCH, 2020, 10 (01)
  • [48] Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
    Spielvogel, Clemens P.
    Ning, Jing
    Kluge, Kilian
    Haberl, David
    Wasinger, Gabriel
    Yu, Josef
    Einspieler, Holger
    Papp, Laszlo
    Grubmueller, Bernhard
    Shariat, Shahrokh F.
    Baltzer, Pascal A. T.
    Clauser, Paola
    Hartenbach, Markus
    Kenner, Lukas
    Hacker, Marcus
    Haug, Alexander R.
    Rasul, Sazan
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [49] Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer
    Samuele Ghezzo
    Paola Mapelli
    Carolina Bezzi
    Ana Maria Samanes Gajate
    Giorgio Brembilla
    Irene Gotuzzo
    Tommaso Russo
    Erik Preza
    Vito Cucchiara
    Naghia Ahmed
    Ilaria Neri
    Sofia Mongardi
    Massimo Freschi
    Alberto Briganti
    Francesco De Cobelli
    Luigi Gianolli
    Paola Scifo
    Maria Picchio
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2548 - 2560
  • [50] Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
    Thomas Franz Fassbender
    Florian Schiller
    Constantinos Zamboglou
    Vanessa Drendel
    Selina Kiefer
    Cordula A. Jilg
    Anca-Ligia Grosu
    Michael Mix
    EJNMMI Research, 10